Abstract:Objective: To compare the expression of serum nucleosome and the antinucleosome antibody family [antinucleosome antibodies,anti-double-stranded DNA(anti-dsDNA) antibodies and antihistone antibodies] by enzyme-linked immunosorbent assay between the healthy controls and patients with systemic lupus erythematosus(SLE) to analye the relationship of the serum soluble nucleosome,the antinu-cleosome antibody family and the organ or system damage in SLE,and to define the role of apoptosis in the relationships.Methods:Seventy-six SLE inpatients were selected from two hospitals,and normal healthy volunteers were recruited as controls(n=69).General information and the data of organ or system damage were collected by self-designed questionnaire containing the Systemic Lupus International Collaborative Clinics/American College of Rheumatology Damage Index(SLICC/ACR DI).Annexin V(AV) and propidium iodide(PI) were used to detect the early apoptosis rate of peripheral blood mononuclear cells(PBMCs).Serum soluble nucleosome levels as well as antinucleosome antibodies,anti-double-stranded DNA antibodies,and antihistone antibodies activities were assessed by Sandwich-enzyme-linked immunosorbent assay(ELISA).Results:Higher levels of antinucleosome antibodies 95.826±94.084 IU/ml,anti-dsDNA antibodies 280.551±305.954 IU/ml and antihistone antibodies 58.557±66.833 IU/ml were found in SLE patients compared with those in normal healthy controls(10.106±0.5348 IU/ml,20.034±12.075 IU/ml,9.290±1.281 IU/ml,respectively).The levels of serum antinucleosome antibodies had a positive correlation with antihistone antibodies(r=0.852,t=13.985,P=0.000),anti-dsDNA antibodies(r=0.788,t=11.028,P=0.000),SLICC/ACR DI(rs=0.552,t=4.23,P=0.000),as well as the early apoptosis rate of PBMCs(r=0.341,t=3.404,P=0.001) in SLE.The levels of serum anti-dsDNA antibodies had a positive correlation with antihistone antibodies(r=0.797,t=11.358,P=0.000),SLICC/ACR DI(rs=0.428,t=3.86,P=0.000),as well as the early apoptosis rate of PBMCs(r=0.385,t=3.917,P=0.000) in SLE.The levels of serum antihistone antibodies had a positive correlation with SLICC/ACR DI(rs=0.390,t=3.74,P=0.000),as well as the early apoptosis rate of PBMCs(r=0.277,t=2.702,P=0.008) in SLE.Increased concentrations of serum soluble antinucleosome antibodies,anti-dsDNA antibodies and antihistone antibodies were found in SLE patients with proteinuria(n=62)(103.221±24.773 IU/ml,305.194±101.912 IU/ml,65.084±18.543 IU/ml,respectively) compared with those in SLE patients without proteinuria(n=14)(63.074±15.478 IU/ml,171.417±66.122 IU/ml,29.652±4.269 IU/ml,respectively)(t=5.796,P=0.0000,t=4.681,P=0.0000,t=3.680,P=0.0004,respectively).Conclusion:The expression of serum antinucleosome antibodies,anti-dsDNA antibodies,and antihistone antibodies are increased among patients with SLE,and the serum antinucleosome antibodies family levels have close relationship with the organ or system damage and the early apoptosis rate of PBMCs in SLE.High expression of serum antinucleosome antibodies family and high PBMCs apoptosis rate are likely to involve in the pathogenesis of SLE.Antinucleosome antibody family may be an important factor for renal involvement in this subgroup of patients with SLE.

The Diagnosis Significance of Serum Anti-Nucleosome Antibodies and Its Value for Lupus Flare in Systemic Lupus Erythematosus

Role of Anti-Nucleosome Antibody in the Diagnosis of Systemic Lupus Erythematosus

Diagnostic Significance of Antinucleosome Antibody for Systemic Lupus Erythematosus

Association Analysis Etween Anti-nucleosome Antibodies: with Clinical Features and Disease Activity in Systemic Lupus Erythematosus of Chinese Han

Significance of combined detection of autoantibodies in systemic lupus erythematosus

Correlation of Anti-Nucleosome Antibodies with Juvenile Systemic Lupus Erythematosus

Values of qualitative assays for anti-ds-DNA and anti-nucleosome antibodies in diagnosis of systemic lupus erythematosus

Anti-Nucleosome Antibody as a Marker of Systemic Lupus Erythematosus Activity

The clinical value of antinuclear antibody spectrum for diagnosing systemic lupus erythematosus

Diagnostic role and pathogenesis of anti-chromatin antibody in systemic lupus erythematosus

Clinical significance of combined detection of autoantibodies in patients with systemic lupus erythematosus

Study of the relationship between renal injury of systemic lupus erythematosus and autoantibodies

Clinical utility of high avidity anti-dsDNA antibody in the diagnosis of systemic lupus erythematosus

Association of expression of serum antinucleosome antibody family with indices of the damage of organ or system in systemic lupus erythematosus

Association of Expression of Serum Antinucleosome Antibody Family and SLE Disease Activity Index

Association of urine autoantibodies with disease activity in systemic lupus erythematosus

A Study on Evidence-Based Laboratory Medicine of the Autoantibodies Detections for Systemic Lupus Erythematosus

Study of the Relationship Between the ANA Anti-dsDNA and the Disease Activity of First Diagnostical SLE In-patients

Analysis of Immunity Index and Immunopathogenesis Pattern of Lupus Nephritis Patients

The relationship between nucleosome and clinical features of systemic lupus erythematosus

Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus.